STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment. Read more about STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment.
A transient increase in eosinophils is associated with prolonged survival in men with metastatic castration-resistant prostate cancer who receive sipuleucel-T. Read more about A transient increase in eosinophils is associated with prolonged survival in men with metastatic castration-resistant prostate cancer who receive sipuleucel-T.
CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells. Read more about CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells.
Reprogramming tumor-infiltrating dendritic cells for CD103+ CD8+ mucosal T-cell differentiation and breast cancer rejection. Read more about Reprogramming tumor-infiltrating dendritic cells for CD103+ CD8+ mucosal T-cell differentiation and breast cancer rejection.
Tumor immunology: multidisciplinary science driving basic and clinical advances. Read more about Tumor immunology: multidisciplinary science driving basic and clinical advances.
